Roivant Social Ventures

Legal name: Roivant Social Ventures Inc

Nonprofit profile at a glance

EIN
833947490
IRS 990 coverage
2021–2024
Official website data refreshed
Jul 2026
Forms available
Form 990 2024, Form 990-EZ 2020
Location
New York, NY, USA
Phone
2128476204
Rating
53
Verdict
MIXED
Rating confidence
Moderate
Sector
Public Foundations

Official website

Reported finances

Revenue
$306,829
Expenses
$287,235
Assets
$408,573
Liabilities
$24,000

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

5 people listed

Executive titles in this filing

  • LINDSAY ANDROSKI (DIRECTOR, PRESIDENT AND CEO)

Highest reported compensation

  • MATTHEW GLINE (DIRECTOR AND SECRETARY): $210,655,137 total reported compensation
  • ERIC VENKER (DIRECTOR): $21,382,228 total reported compensation
  • RAKHI KUMAR TO 22025 (DIRECTOR AND TREASURER): $6,096,416 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

We partner with innovative companies, institutes and organizations to promote systemic, sustained improvements to the way health care is accessed and delivered. Through our unique approach we aim to generate substantial social returns and reinvest financial returns to drive long-term impact.

What it reported doing in 2024

See schedule othe organization had the following initiatives for the fiscal-yearending march 31, 2025:(i) teaching roivant social ventures' "making medicines" course at the university of North Carolina at chapel hill's eshelman school of pharmacy, the number one ranked pharmacy school in the united states. We designed and launched this innovative course in 2023 to introduce pharmd students to the new drug approval process and key issues in drug discovery, pre-clinical testing, clinical trials, fda approval, and global access to medicines. The course is in high demand and received multiple teaching awards. (ii) growing roivant social ventures' inaugural access to medicines pharma internships and access to medicines global fellowships for talented pharmd students from groups with disproportionate unmet needs in medicine. In 2023 the program provided real-world drug development experience to four highly qualified pharmd students. In 2024 we expanded the program to five students. (iii) continuing our thought leadership campaign through hosting events like "increasing impact: leveraging data to drive healthcare access and advancement," that provided increased visibility and education on issues in healthcare access, and speaking at events with organizations like the termeer foundation, bio's ceo and investor conference, the advancing women's leadership in pharma and healthcare conference, the national vaccine law conference, and 50/50 women on boards. (iv) launched our inaugural convergence forum fellowships, which provided support for highly talented first-time female and underrepresented ceos to attend an intimate, invitation only conference of prominent healthcare leaders.(v) launching our health equity spotlight series, which highlights organizations increasing access to research, medicine, and medical care for underserved patient groups.

Operating model

Revenue model
Donor-supported. 99% of the money available for current operations came from contributions and gifts.
Distribution model
Direct operator. The filing allocates 86% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

MIXED - The filed numbers largely add up and program spending has grown recently. A relatively small share of voting board members are independent and a relatively small share of available resources goes toward mission work.

Rating breakdown

  • Financial Efficiency: 54
  • Transparency & Controls: 71
  • Accountability: 23
  • Sustainability: 43
  • Growth: 60

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 53.5%; rating input score 54
  • Program expense ratio: 56.9%; rating input score 57
  • Fundraising efficiency: $12.7 raised per $1 spent on fundraising; rating input score 46; 46th percentile among comparable filings

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 64th percentile among comparable filings
  • Pay-setting controls: 0 of 6 controls in place; rating input score 0
    • Compensation committee: Missing
    • Independent consultant: Missing
    • Other Form 990s reviewed: Missing
    • Written employment contract: Missing
    • Compensation survey or study: Missing
    • Board or committee approval: Missing
  • Foreign activity oversight: Limited
  • Grant itemization coverage: 100%; rating input score 100; 80th percentile among comparable filings
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 0%; rating input score 0; 7th percentile among comparable filings
  • Governance controls: 5 of 9 controls in place; rating input score 56
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: Fail
    • Other executive compensation review process: Fail
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Fail
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 6.4%; rating input score 53; 53rd percentile among comparable filings
  • Total-asset coverage ratio: 1.42; rating input score 50; 50th percentile among comparable filings
  • Liabilities to assets ratio: 0.06; rating input score 31; 31st percentile among comparable filings
  • Officer compensation ratio: 67,381%; rating input score 0; 0th percentile among comparable filings

Growth

  • Program expense growth: 39.5% per year; rating input score 100; 93rd percentile among comparable filings
  • Revenue growth: -0.1% per year; rating input score 0; 23rd percentile among comparable filings
  • Asset growth: 11.5% per year; rating input score 100; 70th percentile among comparable filings

Details

  • What they do: 1 programs and campaigns described on the official site · 1 operating location identified
  • Where the money goes: 53.5% of revenue deployed · 56.9% of spending went to programs
  • Governance: 0 of 5 board members independent · 5 of 9 filing controls reported
  • Programs: 1 filed program accomplishment · $163K in reported program spending
  • Leadership: top reported pay $210.7M · 5 people listed · 0 of 6 pay-setting controls reported
  • Highest-paid contractors: 1 contractor listed · $159K reported
  • Consistency: 20 of 20 current checks pass
  • Schedules: 8 filed schedules · includes major donors, grants, and executive pay
  • Filing history: 4 filing years from 2021 to 2024
  • Contacts: How to reach this organization
  • Money network: 1 filed money-flow record
  • Related organizations: 50 filed related-organization links
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Accountability: Independent voting board scored 0/100.
  • Review — Financial Efficiency: Mission deployment rate scored 54/100.
  • High — Transparency & Controls: Pay-setting controls scored 0/100.
  • Review — Financial Efficiency: Program expense ratio scored 57/100.
  • Review — Accountability: Governance controls: 4 of 9 not reported.
  • Moderate — Financial Efficiency: Fundraising efficiency scored 46/100.
  • High — Growth: Revenue growth scored 0/100.
  • Review — Sustainability: Operating margin scored 53/100.
  • Review — Sustainability: Total-asset coverage ratio scored 50/100.
  • High — Sustainability: Officer compensation ratio scored 0/100.
  • Moderate — Sustainability: Liabilities to assets ratio scored 31/100.